Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-05-06 @ 8:27 PM
Study NCT ID:
NCT05308966
Status:
COMPLETED
Last Update Posted:
2025-10-06
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
Sponsor:
Groupe Francais De Pneumo-Cancerologie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GFPC 04-2021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |